| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.027 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |